Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension

[1]  R. Lopes,et al.  6-Month Outcomes in Patients With Implantable Cardioverter-Defibrillators Undergoing Renal Sympathetic Denervation for the Treatment of Refractory Ventricular Arrhythmias. , 2015, JACC. Cardiovascular interventions.

[2]  M. Böhm,et al.  Atrial Remodeling Following Catheter-Based Renal Denervation Occurs in a Blood Pressure- and Heart Rate-Independent Manner. , 2015, JACC. Cardiovascular interventions.

[3]  U. Schotten,et al.  Catheter-Based Renal Denervation Reduces Atrial Nerve Sprouting and Complexity of Atrial Fibrillation in Goats , 2015, Circulation. Arrhythmia and electrophysiology.

[4]  R. Whitbourn,et al.  First Report of the Global SYMPLICITY Registry on the Effect of Renal Artery Denervation in Patients With Uncontrolled Hypertension , 2015, Hypertension.

[5]  B. Scherlag,et al.  Renal sympathetic denervation for treatment of ventricular arrhythmias: a review on current experimental and clinical findings , 2015, Clinical Research in Cardiology.

[6]  G. Hindricks,et al.  Successful single-sided renal denervation in drug-resistant hypertension and ventricular tachycardia , 2015, Clinical Research in Cardiology.

[7]  E. Wellnhofer,et al.  Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial. , 2014, European heart journal.

[8]  H. Krum,et al.  Sustained Sympathetic and Blood Pressure Reduction 1 Year after Renal Denervation in Patients with Resistant Hypertension , 2022 .

[9]  M. Böhm,et al.  Improvements in left ventricular hypertrophy and diastolic function following renal denervation: effects beyond blood pressure and heart rate reduction. , 2014, Journal of the American College of Cardiology.

[10]  Deepak L. Bhatt,et al.  Refining calcium test for diagnosis of medullary thyroid cancer: cutoffs, procedures and safety , 2014, The New England journal of medicine.

[11]  T. Dickfeld,et al.  Safety and efficacy of renal denervation as a novel treatment of ventricular tachycardia storm in patients with cardiomyopathy. , 2014, Heart rhythm.

[12]  U. Schotten,et al.  Renal denervation: effects on atrial electrophysiology and arrhythmias , 2014, Clinical Research in Cardiology.

[13]  M. Böhm,et al.  Atrial autonomic innervation: a target for interventional antiarrhythmic therapy? , 2014, Journal of the American College of Cardiology.

[14]  M. Böhm,et al.  Renal denervation for treatment of hypertension and beyond , 2014, Clinical Research in Cardiology.

[15]  M. Böhm,et al.  Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension. , 2013, International journal of cardiology.

[16]  B. Williams,et al.  Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. , 2013, European heart journal.

[17]  A. Hughes,et al.  First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study. , 2013, International journal of cardiology.

[18]  U. Schotten,et al.  Renal Sympathetic Denervation Provides Ventricular Rate Control But Does Not Prevent Atrial Electrical Remodeling During Atrial Fibrillation , 2013, Hypertension.

[19]  M. Travin.  Cardiac autonomic imaging with SPECT tracers , 2013, Journal of Nuclear Cardiology.

[20]  S. Mittal,et al.  A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. , 2012, Journal of the American College of Cardiology.

[21]  A. Sato,et al.  High Washout Rate of Iodine‐123‐Metaiodobenzylguanidine Imaging Predicts the Outcome of Catheter Ablation of Atrial Fibrillation , 2011, Journal of cardiovascular electrophysiology.

[22]  H. Krum,et al.  Sympatho-renal axis in chronic disease , 2011, Clinical Research in Cardiology.

[23]  H. Krum,et al.  Device-Based Antihypertensive Therapy: Therapeutic Modulation of the Autonomic Nervous System , 2011, Circulation.

[24]  M. Böhm,et al.  Renal sympathetic denervation for treatment of electrical storm: first-in-man experience , 2011, Clinical Research in Cardiology.

[25]  H. Krum,et al.  Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial , 2010, The Lancet.

[26]  A. Mahajan,et al.  Neuraxial Modulation for Refractory Ventricular Arrhythmias: Value of Thoracic Epidural Anesthesia and Surgical Left Cardiac Sympathetic Denervation , 2010, Circulation.

[27]  M. Cerqueira,et al.  Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. , 2010, Journal of the American College of Cardiology.

[28]  W. J. Elliott,et al.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study , 2010 .

[29]  M. Cowie,et al.  Cardiac sympathetic imaging with mIBG in heart failure. , 2010, JACC. Cardiovascular imaging.

[30]  Javed Butler,et al.  The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. , 2009, Journal of the American College of Cardiology.

[31]  M. Ackerman,et al.  Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery. , 2009, Heart rhythm.

[32]  D. Zipes.  Heart-brain interactions in cardiac arrhythmias: role of the autonomic nervous system. , 2008, Cleveland Clinic journal of medicine.

[33]  M. Cheitlin.  Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging , 2008 .

[34]  D. DeMets,et al.  Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure: Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study , 2002, Circulation.

[35]  M. Hori,et al.  Prognostic significance of cardiac 123I metaiodobenzylguanidine imaging for mortality and morbidity in patients with chronic heart failure: a prospective study , 2001, Heart.

[36]  M. Shirotani,et al.  Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension. , 1999, Hypertension.

[37]  M. Shirotani,et al.  Comparison of effects of enalapril and nitrendipine on cardiac sympathetic nervous system in essential hypertension. , 1998, Journal of the American College of Cardiology.

[38]  K. Fukuchi,et al.  Myocardial iodine-123-metaiodobenzylguanidine images and autonomic nerve activity in normal subjects. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[39]  W. Mitsuoka,et al.  Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause. , 1995, Journal of the American College of Cardiology.

[40]  W. Anderson,et al.  Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. , 1988, Hypertension.